The FDA has approved Wegovy (semaglutide 2.4 mg) and Zepbound (tirzepatide) for chronic weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity
Eating Tips Eat protein first at every meal
Understanding the gut microflora, associations among the microbiome and inflammasomes, the immune system, the role of gut microbiota metabolites, and gut permeability may lead to the development of preventive strategies for CVDs (Noor et al., 2021)
AOD 9604 is a peptide, which is simply a short chain of amino acids
According to the IFEBP survey, the top 10 factors when considering covering GLP-1 drugs for obesity are: Obesity as a risk factor for chronic diseases and associated costs Drug shortages Impact/effectiveness of cost-control mechanisms Existing coverage through government programs Long-term costs Patient and prescriber demand Broker/consultant/ PBM recommendations Lack of long-term use clinical studies of GLP-1 drugs Side effects Similar drugs in research and development The cost of these drugs can range from a minimum of $200 to $300 a month, and this cost would stretch over a long period of time, as GLP-1 drugs for weight loss require prolonged use, Bajaj said
Eli Lilly needs to compile and submit the data to the FDA in the US first
